People with attention deficit hyperactivity disorder (ADHD) frequently read warnings on their medication bottles instructing them to avoid usage if they have structural heart problems or another pre-existing heart condition.

U.S. Food and Drug Administration officials have announced that cholesterol-lowering drug fenofibric acid (Trilipix) might not lower a patient's risk of having a heart attack or stroke.

Taking action today will deliever many health benefits tomorrow. Patients who have already had a heart attack or stroke require substantial lifestyle changes to improve their quality of life.

U.S. Food and Drug Administration officials have given the green light to anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in patients with a common heart arrhythmia called atrial fibrillation.

After a stroke some patients may find it easier to quit smoking. There may be a good reason for that. Smokers who intended to stop prior to the stroke and those who have a particular area of their brain damaged by stroke are more likely to quit.

After a stroke it's common to suffer secondary damage in the days or weeks following the initial brain attack. A protein may be the key to preventing later damage to the brain.

An unexpected finding in pythons may have implications for treating human heart disease. Fatty acids circulating in the blood streams of the snakes were found to promote heart growth--a discovery that could aid in development of treatments for humans.

People with rheumatoid arthritis suffer from inflammation of the joints. That inflammation can spread to other organs, causing additional health problems. Atherosclerosis (hardened arteries) may be one of these problems.

Statins are widely prescribed to lower cholesterol and reduce the risk of heart attacks and strokes. Though effective, some doctors have become concerned about a rare gene that increases the risk of muscle aches, kidney damage and death in those who also take statins.

Kidney disease patients face a high risk of heart-related events like stroke. As such, patients need ways to protect against potentially deadly problems. Now, health advisors are backing a drug that does just that.